Massachusetts 2025-2026 Regular Session

Massachusetts House Bill H4686

Introduced
3/27/25  
Refer
3/27/25  
Refer
10/27/25  

Caption

Relative to Topical Steroid Withdrawal Syndrome

Impact

If enacted, H4686 would amend Chapter 111 of the General Laws by adding Section 245, which would legally formalize the creation of a commission composed of various stakeholders. This commission would not only include healthcare professionals, such as dermatologists and pediatricians, but also individuals who have personally experienced TSWS. The commission's mandate includes conducting public hearings and forums to gather pertinent information, which could contribute to more effective medical protocols and better educational outreach regarding the syndrome, ultimately aiming to improve patient care and awareness concerning the risks of topical steroids.

Summary

House Bill H4686, titled 'An Act relative to Topical Steroid Withdrawal Syndrome,' aims to establish a state commission dedicated to researching topical steroid addiction and the associated syndrome that can arise from either intentional or unintentional exposure to topical steroids. This legislation recognizes the severe impact of Topical Steroid Withdrawal Syndrome (TSWS), emphasizing the need for comprehensive research and preventive measures to better inform both healthcare providers and patients regarding the risks of topical steroid usage. The bill is a response to increasing concerns among individuals who have suffered from TSWS and highlights the importance of evidence-based healthcare practices.

Contention

While the bill has a clear intent to address a significant health issue, it may face various points of contention. Advocates for the bill argue that the formal establishment of a commission will help to ensure that healthcare providers are adequately informed about TSWS and can, therefore, offer necessary warnings when prescribing topical steroids. However, opponents may raise concerns over the funding and resource allocation for the commission, questioning the feasibility of its initiatives. Additionally, there may be discussions regarding the need for balancing the interests of pharmaceutical companies that manufacture topical steroids with the necessity of protecting patient health and safety.

Companion Bills

No companion bills found.

Previously Filed As

MA H4115

Topical Steroid Withdrawal Syndrome Awareness Day

MA HCR178

Recognizing February 3 As Topical Steroid Withdrawal Syndrome Awareness Day.

MA HR174

Recognizing February 3 As Topical Steroid Withdrawal Syndrome Awareness Day.

MA HR135

Topical Steroid Withdrawal Syndrome Awareness Day at the state capitol; 2/3/25; recognize

MA J01485

Memorializing Governor Kathy Hochul to proclaim February 3, 2026, Topical Steroid Withdrawal Awareness Day in the State of New York

MA H1665

Related to Down syndrome

MA H2546

Related to unborn victims of Down Syndrome

MA H1170

Relative to access to care for Ehler Danlos syndrome patients

MA H3305

Designating June 7 as Tourette Syndrome awareness day

MA S2152

Designating June 7 as Tourette Syndrome Awareness Day

Similar Bills

No similar bills found.